Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Organisation › Details

Alligator Bioscience AB (Nasdaq Stockholm: ATORX)

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s growing pipeline includes four lead clinical and pre-clinical drug candidates (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527). ADC-1013 (JNJ-64457107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator’s shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. *


Period Start 2000-12-01 established
  Group Alligator Bioscience (Group)
  Predecessor University of Lund (Lund University)
Products Industry FIND® technology (Fragment INduced Diversity)
  Industry 2 ADC-1013 (Alligator Bioscience / JnJ)
Persons Person Norlén, Per (Alligator Bioscience 201606 CEO)
  Person 2 Benson, Peter (Sunstone Capital 200705– Managing Partner Life Science Ventures)
Region Region Lund
  Country Sweden
  City 223 81 Lund
  Tel +46-46-286-4280
    Address record changed: 2018-07-24
Basic data Employees B: 11 to 50 (2018-01-18)
  Currency SEK
  Annual sales 56,875,000 (sales, net, consolidated (2017) 2017-12-31)
  Profit -63,758,000 (2017-12-31)
  Cash 547,041,000 (2017-12-31)
    * Document for �About Section�: Alligator Bioscience AB. (1/18/18). "Press Release: Alligator Bioscience Appoints New VP Business Development". Lund.
Record changed: 2019-08-22


Picture [LSA] – The Business Web Portal 650x89px

More documents for Alligator Bioscience (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

» top